Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
23
|
pubmed:dateCreated |
1977-2-24
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0301-0481
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
51
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
989-92
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1007362-Administration, Oral,
pubmed-meshheading:1007362-Adolescent,
pubmed-meshheading:1007362-Adult,
pubmed-meshheading:1007362-Alopecia Areata,
pubmed-meshheading:1007362-Child,
pubmed-meshheading:1007362-Dapsone,
pubmed-meshheading:1007362-Female,
pubmed-meshheading:1007362-Humans,
pubmed-meshheading:1007362-Male,
pubmed-meshheading:1007362-Methylprednisolone,
pubmed-meshheading:1007362-Middle Aged
|
pubmed:year |
1976
|
pubmed:articleTitle |
[Sulfone therapy in alopecia areata].
|
pubmed:publicationType |
Journal Article
|